On the Origin of Pancreatic Cancer: Molecular Tumor Subtypes in Perspective of Exocrine Cell Plasticity

Cell Mol Gastroenterol Hepatol. 2022;13(4):1243-1253. doi: 10.1016/j.jcmgh.2021.11.010. Epub 2021 Dec 4.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a devastating type of cancer. While many studies have shed light into the pathobiology of PDAC, the nature of PDAC's cell of origin remains under debate. Studies in adult pancreatic tissue have unveiled a remarkable exocrine cell plasticity including transitional states, mostly exemplified by acinar to ductal cell metaplasia, but also with recent evidence hinting at duct to basal cell transitions. Single-cell RNA sequencing has further revealed intrapopulation heterogeneity among acinar and duct cells. Transcriptomic and epigenomic relationships between these exocrine cell differentiation states and PDAC molecular subtypes have started to emerge, suggesting different ontogenies for different tumor subtypes. This review sheds light on these diverse aspects with particular focus on studies with human cells. Understanding the "masked ball" of exocrine cells at origin of PDAC and leaving behind the binary acinar vs duct cell classification may significantly advance our insights in PDAC biology.

Keywords: Heterogeneity; Metaplasia; Pancreas.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acinar Cells / pathology
  • Carcinoma, Pancreatic Ductal* / pathology
  • Cell Plasticity
  • Humans
  • Pancreatic Neoplasms* / pathology